Cymra Life Sciences
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Cymra Life Sciences is a biotechnology company that cultivates and manufactures organic medical cannabis products for the treatment of chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cymra Life Sciences Comparables
Compare Cymra Life Sciences with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tasmanian Botanics | 87% | |
| Medcan Australia | 87% | |
| Australian Natural Therapeutics Group | 86% | |
Cymra Life Sciences Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 44% MoM, reaching 2.9K.
- May 11, 2026
Monthly visitors grew 350% MoM, reaching 2.4K.
Cymra Life Sciences Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Cymra Life Sciences's valuation, stock price, and market status.